Study Evaluating IV Methylnaltrexone for the Treatment of Post Operative Ileus
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
Primary Objective: In subjects who have undergone segmental colectomy, the time between the
end of surgery and first bowel movement is significantly shorter with the investigational
MOA-728 regimen than with a placebo regimen.
Phase:
Phase 3
Details
Lead Sponsor:
Bausch Health Americas, Inc. Valeant Pharmaceuticals International, Inc.